Skip To Main Content
Patrick O'Keefe on Muck Rack

Patrick O'Keefe

Daytona Beach
As seen in: Apple Podcasts, Medium, Wiley Online Library, Psychology Today, Detroit News, Crain's Detroit Business, The Bulletin (Bend, OR), Rockford Register Star, RealClear Defense, Batavia Daily News and
COO for @anedot. @hubspot Customer Advisory Board 2026. Fmr: ED @mdgop, PD Political Comms @ufjschool

Get in touch with Patrick

Contact Patrick, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Opinion: Crain’s Forum reveals sobering trends in higher education

|
By Patrick O'Keefe
| Crain's Detroit Business Verified
Crain’s analysis of the 12-year trend of enrollment and the respective finances of colleges and universities in Michigan should have been sobering. Patrick O'Keefe Many of our Michigan colleges and universities have lost over 25% of their enrollment. Not one university that lost enrollment cut its expenses sufficiently to make up the shortfall in revenue from that decline. In the case of those few universities that had an increase in enrollment, they had a substantially higher increase in expenses.
Open in Who Shared Issue with article?

Don't pass legislation allowing more lawsuits about insurance

|
By Patrick O'Keefe
| The Bulletin (Bend, OR) Verified
If you have been hit with an increase in your home or auto insurance premium in the past year, you're not alone. I know. I work in the industry right here in Bend/Redmond and even my own personal insurance costs more than it did a year ago. Wildfires and winter storms are causing costly damage to homes and businesses, while fixing more high-tech cars and treating injuries from auto accidents are all adding up to higher claims payouts here and across the country.
Open in Who Shared Issue with article?

Navigating the Complexities of Alzheimer’s Clinical Trials: The Perils of Small Molecule Studies and the Risk of Fraudulent Practices

|
By Patrick O'Keefe, Suzanne Hendrix, jeffery Zhang, Drome Burgundy
| Wiley Online Library Verified
Background Alzheimer’s disease (AD) presents unique challenges in clinical trials involving small molecules. Multifaceted issues plague such trials, emphasizing susceptibility to fraud from clinical sites and “professional patients”. The relative ease of simulating Alzheimer’s diagnosis, coupled with inadequate oversight by Contract Research Organizations (CROs), creates fertile ground for deceptive practices. Poor rater quality and the simplicity of falsifying data exacerbate concerns.
Open in Who Shared Issue with article?
See all 16 licensed articles (20 Total)